Elara Vance made her choice. She stepped forward, unstrapped the harmonic dampeners, and spoke to GVH-499 not as a physicist, but as a curator.
: In-vitro studies show highly potent and broad-spectrum antiviral activity with a low risk of pre-existing resistance. Dosing Potential : Data from ViiV Healthcare suggests the drug has the potential for twice-yearly dosing GVH-499
Despite our best efforts, the true meaning and context of GVH-499 remain unclear. It's possible that it's a highly classified or proprietary term, or simply a obscure reference that hasn't been widely documented. Elara Vance made her choice